The First Affiliated Hospital Of University Of Science And Technology Of China
Clinical trials sponsored by The First Affiliated Hospital Of University Of Science And Technology Of China, explained in plain language.
-
Race against time: new hope for stroke patients when standard treatment Isn't available
Disease control Not yet recruitingThis study tests whether the clot-busting drug tenecteplase can help stroke patients who arrive at the hospital 4.5 to 24 hours after symptoms begin, when the standard mechanical clot removal procedure isn't available. Researchers will compare giving the drug against standard med…
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Triple-Threat attack on tough rectal cancers
Disease control Not yet recruitingThis study is testing a new approach for patients with rectal cancer that has a high risk of coming back. It combines three treatments—chemotherapy, radiation, and an immunotherapy drug—all given before surgery. The main goal is to see if this powerful combination can completely …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New hope for stroke patients: drug trial aims to boost brain recovery after clot removal
Disease control Not yet recruitingThis study is testing if adding the drug baricitinib to the standard emergency procedure to remove a large blood clot in the brain helps people recover better from a major stroke. It will involve 750 adults who have had this type of stroke and received the clot-removal treatment.…
Phase: PHASE2, PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC